Results 281 to 290 of about 100,641 (375)
Acute Pharmacodynamic Effects of Oral Levodopa on Blood Pressure in Parkinson's Disease. [PDF]
Longardner K +7 more
europepmc +1 more source
State-dependent modulation of spiny projection neurons controls levodopa-induced dyskinesia in a mouse model of Parkinson's disease. [PDF]
Zhai S +7 more
europepmc +1 more source
Levodopa-induced dyskinesias in Parkinson’s disease: emerging treatments
P Bargiotas, S Konitsiotis
openalex +1 more source
rs6971 TSPO polymorphism in Parkinson's disease
Movement Disorders, EarlyView.
Bina Patel +9 more
wiley +1 more source
Monoaminergic Networks of Cognitive and Behavioral Symptoms in Early Parkinson's Disease
Abstract Background Parkinson's disease (PD) is associated with several behavioral and cognitive symptoms, the neurobiological background of which is not yet fully understood. Objectives The aim was to investigate the association between monoamine function and four specific nonmotor symptoms in early PD using the Parkinson's Progression Markers ...
Kalle J. Niemi +3 more
wiley +1 more source
A Hidden Risk of Levodopa: A Case Report of Drug-Induced Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) and Hyponatraemia. [PDF]
Haddy S +3 more
europepmc +1 more source
Plasma Glucosylsphingosine in GBA1 E365K, N409S, and L483P Heterozygous Mutation Carriers
Abstract Background GBA1 encodes the lysosomal enzyme glucocerebrosidase, with key substrates that include glucosylceramide and glucosylsphingosine. The E365K variant is the most common variant in GBA1 that is associated with Parkinson's disease (PD) but is not associated with Gaucher disease.
Julian Agin‐Liebes +7 more
wiley +1 more source

